lbm lbmtm tirzepatide nano-microneedle patch Lmipki® NIDDK-Tirzepatide Nano Microneedle 𝗛𝗼𝗻𝘅𝗶® 𝗡𝗜𝗗𝗗𝗞-𝗧𝗶𝗿𝘇𝗲𝗽𝗮𝘁𝗶𝗱𝗲 𝗡𝗮𝗻𝗼 𝗠𝗶𝗰𝗿𝗼𝗻𝗲𝗲𝗱𝗹𝗲 𝗣𝗮𝘁𝗰𝗵

Zepbound (tirzepatide) is not FDA-approved for type 1 diabetes, but emerging real-world evidence demonstrates it can be used off-label with significant benef...

Renal and cardiovascular protection, reducing the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease

However, individual response varies significantly based on metabolic factors, genetics, and GLP-1 receptor sensitivity

Rated 4.5/5

Data from the UKs medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), has revealed that since glucagon-like peptide-1 receptor agonists (GLP-1) were licensed there have been hundreds of cases of acute and chronic pancreatitis among people taking GLP-1 medicines

In SURMOUNT-4, all participants received tirzepatide (Mounjaro, Eli Lilly) during a lead-in phase, with the study population achieving a mean weight loss of 20.2% at 36 weeks